These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 514429)

  • 1. Behavior of amikacin in renal parenchyma of normal rats and of rats with acute obstructive renal insufficiency.
    Rudhardt M; Fabre J
    Nephron; 1979; 24(6):287-91. PubMed ID: 514429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance.
    Pijck J; Hallynck T; Soep H; Baert L; Daneels R; Boelaert J
    J Infect Dis; 1976 Nov; 134 SUPPL():S331-41. PubMed ID: 993626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.
    Xerri L; Orsolini P; Broggio R
    Chemioterapia; 1984 Oct; 3(5):271-7. PubMed ID: 6398124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats.
    Fabre J; Rudhardt M; Blanchard P; Regamey C
    Kidney Int; 1976 Dec; 10(6):444-9. PubMed ID: 1011538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
    Brown MP; Gronwall RR; Martinez DS; Beal C
    Am J Vet Res; 1986 Feb; 47(2):453-4. PubMed ID: 3954234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffusion of amikacin in the lungs].
    Saux MC; Crockett R; Fourtillan JB; Leng B; Couraud L
    Pathol Biol (Paris); 1986 Feb; 34(2):113-7. PubMed ID: 3517776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment.
    Lanao JM; Navarro AS; Dominguez-Gil A; Tabernero JM; Rodriguez IC; Gonzalez Lopez A
    J Antimicrob Chemother; 1983 Nov; 12(5):481-8. PubMed ID: 6671925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of aminoglycosides in young and adult rats.
    Provoost AP; Adejuyigbe O; Wolff ED
    Pediatr Res; 1985 Nov; 19(11):1191-6. PubMed ID: 4069829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of amikacin in children with normal and impaired renal function.
    Lanao JM; Dominguez-Gil AA; Dominguez-Gil A; Málaga S; Crespo M; Santos F
    Kidney Int; 1981 Jul; 20(1):115-21. PubMed ID: 7300106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin serum concentrations: prediction of levels and dosage guidelines.
    Sarubbi FA; Hull JH
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):612-8. PubMed ID: 717929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of amikacin half-life during therapy in patients with renal insufficiency.
    Blaser J; Rüttimann S; Bhend H; Lüthy R
    Antimicrob Agents Chemother; 1983 Jun; 23(6):888-91. PubMed ID: 6614893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum creatinine concentration and amikacin half-life.
    Levy J; Klastensky J
    J Clin Pharmacol; 1975 Oct; 15(10):705-7. PubMed ID: 1102570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin nephrotoxicity in the rat.
    Houghton DC; Plamp CE; Gilbert DN; Kohlhepp SJ; Bennett WM; Porter GA; DeFehr J; Webb M
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):277-91. PubMed ID: 7217852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amikacin and kanamycin. Comparative experimental studies on nephrotoxicity].
    Züllich B; Sack K
    Arzneimittelforschung; 1978; 28(2):271-8. PubMed ID: 580391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amikacin for treatment of urinary tract infections in patients with reduced renal function.
    Höffler D; Koeppe P; Demers HG
    J Infect Dis; 1976 Nov; 134 SUPPL():S369-73. PubMed ID: 993628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.